
Gainers
- ESSA Pharma Inc. (NASDAQ:EPIX) shares climbed 180.2% to close at $4.82 on Wednesday after the company highlighted updates results from the Phase 1/2 study of EPI-7386 with Enzalutamide At the 29th Annual Prostate Cancer Foundation Scientific Retreat.
- OneConnect Financial Technology Co., Ltd. (NASDAQ:OCFT) surged 45.8% to close at $0.9040.
- RLX Technology Inc. (NYSE:RLX) jumped 43% to close at $1.63.
- Cipher Mining Inc. (NASDAQ:CIFR) gained 42.6% to close at $1.18.
- Loyalty Ventures Inc. (NASDAQ:LYLT) jumped 39.6% to close at $1.15.
- Eqonex Limited (NASDAQ:EQOS) climbed 38.2% to close at $0.47.
- Freight Technologies, Inc. (NASDAQ:FRGT) gained 37.4% to close at $0.5910.
- Freight Technologies expanded Relationship with leading glass container manufacturer to incorporate Canadian routes.
- Femasys Inc. (NASDAQ:FEMY) surged 33% to close at $1.41.
- LMF Acquisition Opportunities, Inc. (NASDAQ:LMAO) gained 30.3% to close at $9.00.
- New Oriental Education & Technology Group Inc. (NYSE:EDU) shares surged 28.3% to close at $27.02 after the company reported better-than-expected Q1 EPS and sales results.
- Vapotherm, Inc. (NYSE:VAPO) gained 28% to close at $1.60.
- Cosmos Holdings Inc. (NASDAQ:COSM) shares gained 27.8% to close at $0.1116. Cosmos Holdings CEO Grigorios Siokas bought a total of 12,500,000 shares at an average price of $0.12.
- GeoVax Labs, Inc. (NASDAQ:GOVX) jumped 27% to close at $1.11. HC Wainwright & Co. initiated coverage on Geovax Labs with a Buy rating and announced a price target of $8.
- GreenPower Motor Company Inc. (NASDAQ:GP) gained 23.4% to settle at $2.53.
- Argo Blockchain plc (NASDAQ:ARBK) climbed 22.9% to close at $2.31 after jumping 36% on Tuesday.
- Nabors Industries Ltd. (NYSE:NBR) rose 22.4% to close at $168.20 following strong quarterly sales.
- Helix Energy Solutions Group, Inc. (NYSE:HLX) gained 18.9% to close at $6.16. BTIG upgraded Helix Energy Solutions from Neutral to Buy and announced a $10 price target.
- ChampionX Corporation (NASDAQ:CHX) gained 18.2% to settle at $29.15 after the company reported Q3 results and announced a $750 million buyback authorization.
- Rumble Inc. (NASDAQ:RUM) climbed 18% to close at $10.01 after jumping over 18% on Tuesday.
- TuanChe Limited (NASDAQ:TC) gained 17.7% to settle at $7.44.
- SharpLink Gaming Ltd. (NASDAQ:SBET) rose 15.4% to close at $0.7848 after gaining around 7% on Tuesday.
- Tenable Holdings, Inc. (NASDAQ:TENB) climbed 15% to close at $39.36 following strong Q3 results.
- HUTCHMED (China) Limited (NASDAQ:HCM) gained 14.5% to settle at $8.76.
- Agilysys, Inc. (NASDAQ:AGYS) surged 13.3% to close at $62.15 following better-than-expected Q2 results.
- Universal Health Services, Inc. (NYSE:UHS) climbed 13.1% to close at $109.37 following strong quarterly results.
- Sunrise New Energy Co., Ltd. (NASDAQ:EPOW) gained 12.7% to close at $4.16.
- Arvinas, Inc. (NASDAQ:ARVN) rose 12% to close at $49.44.
- Addex Therapeutics Ltd (NASDAQ:ADXN) gained 11.6% to settle at $0.8150.
- MINISO Group Holding Limited (NASDAQ:MNSO) gained 10.9% to close at $5.59.
- Kanzhun Limited (NASDAQ:BZ) rose 10.2% to close at $12.46.
- Enphase Energy, Inc. (NASDAQ:ENPH) climbed 9.9% to close at $291.87 after the company reported better-than-expected Q3 adjusted EPS and sales results and issued Q4 revenue guidance above estimates.
- RPC, Inc. (NYSE:RES) climbed 9.9% to close at $10.14 following upbeat earnings.
- United Maritime Corporation (NASDAQ:USEA) rose 9.6% to close at $2.73. United Maritime initiated additional $3 million stock buyback plan.
- Community Health Systems, Inc. (NYSE:CYH) shares climbed 8.5% to close at $2.30. The company is set to release quarterly earnings after the closing bell today.
- Sintx Technologies, Inc. (NASDAQ:SINT) gained 6.8% to close at $0.1101 after the company announced it was awarded a multi-year DARPA contract to develop CMCs and high temperature coatings for turbine engines.
- Hyperfine, Inc. (NASDAQ:HYPR) gained 6.3% to close at $0.9883.
- TransCode Therapeutics, Inc. (NASDAQ:RNAZ) gained 5.5% to close at $1.15 after the company reported preclinical results with its lead candidate, TTX-MC138 in Pancreatic Adenocarcinoma.